| Choksi Laboratories Ltd | Industry : (Healthcare) | |
|---|---|---|
|
BSE Code : 526546 |
NSE Symbol : - |
P/E(TTM) : 73.79 |
|
ISIN Demat : INE493D01013 |
Div & Yield% : 0.00 |
EPS(TTM) : 2.73 |
|
Book Value(₹) : 36.72 |
Market Cap(₹Cr) : 140.32 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 12.06 | 12.82 | 10.82 | 11.12 | 11.24 | 11.40 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 12.06 | 12.82 | 10.82 | 11.12 | 11.24 | 11.40 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.02 | 0.06 | 0.89 | 0.01 | 0.00 | 0.04 |
| Total Income | 12.08 | 12.88 | 11.71 | 11.13 | 11.25 | 11.44 |
| Total Expenditure | 8.78 | 9.18 | 8.17 | 8.19 | 8.34 | 7.90 |
| PBIDT | 3.30 | 3.71 | 3.55 | 2.94 | 2.90 | 3.55 |
| Interest | 0.73 | 0.71 | 0.81 | 0.69 | 0.60 | 0.58 |
| PBDT | 2.57 | 2.99 | 2.74 | 2.25 | 2.30 | 2.96 |
| Depreciation | 1.97 | 1.89 | 1.83 | 1.69 | 1.68 | 1.70 |
| Tax | 0.18 | 0.14 | 0.41 | 0.27 | 0.12 | 0.59 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.16 | -0.07 | 0.18 | 0.05 | 0.12 | -0.25 |
| Reported Profit After Tax | 0.58 | 1.03 | 0.31 | 0.24 | 0.39 | 0.92 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.26 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.58 | 1.03 | 0.05 | 0.24 | 0.39 | 0.92 |
| EPS (Unit Curr.) | 0.84 | 1.47 | 0.45 | 0.35 | 0.55 | 1.32 |
| EPS (Adj) (Unit Curr.) | 0.84 | 1.47 | 0.45 | 0.35 | 0.55 | 1.32 |
| Calculated EPS (Unit Curr.) | 0.84 | 1.47 | 0.45 | 0.35 | 0.55 | 1.32 |
| Calculated EPS (Adj) (Unit Curr.) | 0.84 | 1.47 | 0.45 | 0.35 | 0.55 | 1.32 |
| Calculated EPS (Ann.) (Unit Curr.) | 3.34 | 5.90 | 1.78 | 1.39 | 2.21 | 5.29 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 3.34 | 5.90 | 1.78 | 1.39 | 2.21 | 5.29 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 6.97 | 6.97 | 6.97 | 6.97 | 6.97 | 6.97 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 27.36 | 28.94 | 32.81 | 26.44 | 25.80 | 31.14 |
| PBDTM(%) | 21.31 | 23.32 | 25.32 | 20.23 | 20.46 | 25.96 |
| PATM(%) | 4.81 | 8.03 | 2.87 | 2.16 | 3.47 | 8.07 |
